Bristol-Myers Squibb
- Price
- 62.09 USD
- Fair value
- 27.86 USD
- Discount to fair value
- −123%
- Mkt cap
- 126.79B
- P/E
- 18.0×
- P/B
- 6.86×
- EV
- 163.72B
- Div yield
- 3.98%
- ROE
- 38.2%
- Net margin
- 14.6%
Current price62.09USD
Fair value (est., median)27.86USD
UndervaluedFair valueOvervalued
+122.8% above fair valueWould need to fall ~55.1% to reach fair value.
Median ofDCF 99.12DDM 35.69Graham 23.78Residual Income 27.86Earnings Power 23.16
Health Check
43
Overall / 100
Good (66+)Caution (40–65)Risk (<40)
Rewards
- Strong return on equity (38.2%).
Risks
- Trades 122.8% above estimated fair value.
- Stretched balance sheet / elevated debt.
- Low fair-value confidence — methods disagree or data is thin.
- Expensive on book (P/B 6.9×).
Scores are computed automatically from the real financial statements (Value from fair value; the rest from growth, profitability, balance sheet and dividends). A decision aid, not investment advice.
Price, corporate actions & news
Demo series
D — DividendS — Split▲ good · ▼ bad newstap a marker for details
Growth & profitability
Revenue, net income and margin.
RevenueNet incomeNet margin %tap a bar for figures
Key figures
Covers 19 years · FY2007–FY2025
| Metric | FY'21 | FY'22 | FY'23 | FY'24 | FY'25 |
|---|---|---|---|---|---|
| Revenue | 46.38B | 46.16B | 45.01B | 48.30B | 48.19B |
| Net Income | 6.99B | 6.33B | 8.03B | -8.95B | 7.05B |
| Net Margin | 15.1% | 13.7% | 17.8% | -18.5% | 14.6% |
| Operating Cash Flow | 16.21B | 13.07B | 13.86B | 15.19B | 14.16B |
| OCF Margin | 34.9% | 28.3% | 30.8% | 31.4% | 29.4% |
| Capital Expenditure | 973.00M | 1.12B | 1.21B | 1.25B | 1.31B |
| Free Cash Flow | 15.23B | 11.95B | 12.65B | 13.94B | 12.85B |
| FCF Margin | 32.8% | 25.9% | 28.1% | 28.9% | 26.7% |
| FCF Conversion | 217.8% | 188.8% | 157.6% | 155.8% | 182.1% |
| EPS (Diluted) | 3.43/sh | 3.10/sh | 3.93/sh | -4.38/sh | 3.45/sh |
| Dividend / Share | 2.15/sh | 2.27/sh | 2.32/sh | 2.38/sh | 2.47/sh |
Dividend return (if you buy today)if you buy today
Dividend yield3.98%
Dividend / share2.47 USD
If you invest
USD
Shares (≈)161
Est. annual income397.75 USD
At this rate, dividends alone return your capital in ~25.1 years.
Dividend history
Dividend / share & historical yield (USD).
Dividend / share yield %tap a bar for figures
Quarterly dividends & yield
Per-share dividends by quarter, full-year total, and yield on the year's average price · USD
| Year | Q1 | Q2 | Q3 | Q4 | Full year | Yield (avg) |
|---|---|---|---|---|---|---|
| 2026 | — | 0.63 | 0.63 | — | 1.26 | 2.2% |
| 2025 | — | — | — | — | 2.47 | 4.8% |
| 2024 | — | — | — | — | 2.38 | 4.5% |
| 2023 | — | — | — | — | 2.32 | 4.1% |
| 2022 | — | — | — | — | 2.27 | 3.1% |
Corporate actions
DCash Dividend
0.63 USD /sh2026-07-02
DCash Dividend
0.63 USD /sh2026-04-02
DCash Dividend
0.36 USD /sh2014-07-01
DCash Dividend
0.36 USD /sh2014-04-02
DCash Dividend
0.36 USD /sh2013-12-31
DCash Dividend
0.35 USD /sh2013-10-02
DCash Dividend
0.35 USD /sh2013-07-02
DCash Dividend
0.35 USD /sh2013-04-03
DCash Dividend
0.35 USD /sh2013-01-02
DCash Dividend
0.34 USD /sh2012-10-03
Valuation breakdown
Fair value = median of the applicable methods (DCF، DDM، Graham، Residual Income، Earnings Power).
Each method below is a different lens on the same company — no single method dominates the result.
Discounted Cash Flow
Values the company from the future cash it's expected to generate. · Tap to adjust assumptions
99.12 USD
Dividend Discount Model
Values the share from the dividends it's expected to keep paying. · Tap to adjust assumptions
35.69 USD
Graham Number
A conservative benchmark built from earnings and book value. · Tap to adjust assumptions
23.78 USD
Residual Income (justified P/B)
Values the profit the company earns above the cost of its equity. · Tap to adjust assumptions
27.86 USD
Earnings Power Value
Values today's earning power as-is, assuming no growth. · Tap to adjust assumptions
23.16 USD
DCF only is anchored on FY2025 — the latest year with positive cash flow that supports a value. The other methods (DDM, Graham, RIM, EPV) use current / normalized figures.
Fair Value (median)27.86 USD
▸ Show assumptions▾ Assumptions
- Effective discount rate
- 10.13%
- CAPM cost of equity
- 12.00%
- Risk-free rate
- 4.50%
- Equity risk premium
- 7.50%
- DCF growth (stage 1)
- 8.00%
- DCF terminal growth
- 3.00%
- DCF forecast years
- 10
- DDM dividend growth
- 3.00%
Tune these per company in the Hajras Odoo backend; values recompute automatically.
Wealth simulator
What if you'd invested in Bristol-Myers Squibb regularly?
Starting year
- Invested
- 1K/yr · 43K total(1984 → today · 43 yrs)
- your value today is
- 151.3K USD
- Total return
- +251.8%(+73.1% Dividends · +178.6% Capital gain)
- Annualised (IRR)
- +6.6%
Invested43KUSD
Dividends31.5KUSD
Capital gain76.8KUSD
InvestedCapital gainDividendstap a bar for figures
Community Notes0
No notes yet. Be the first to share a thesis.